Clinical Outcomes of Proton Beam Therapy for Ground-Glass Opacity-Type Lung Cancer
Ichiro Nagata,1,2 Takashi Ogino,1 Takeshi Arimura,1 Takashi Yoshiura2 1Medipolis Proton Therapy and Research Center, Ibusuki, Kagoshima, Japan; 2Department of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, JapanCorrespondence: Ichiro NagataMedipolis Proto...
Guardado en:
Autores principales: | Nagata I, Ogino T, Arimura T, Yoshiura T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ca552fdc24046b8ae9aaf5383448536 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Editorial: New Trends in Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: Clinical, Pathological and Molecular Aspects
por: Kezhong Chen, et al.
Publicado: (2021) -
Synchronous microwave ablation followed by core‐needle biopsy via a coaxial cannula for highly suspected malignant lung ground‐glass opacities: A single‐center, single‐arm retrospective study
por: FanLei Kong, et al.
Publicado: (2021) -
Chemotherapy-Associated Pulmonary Toxicity—Case Series from a Single Center
por: Tilak TVSVGK, et al.
Publicado: (2021) -
Pulmonary eosinophilia may indicate onset stage of allergic bronchopulmonary aspergillosis
por: Mari Miki, et al.
Publicado: (2021) -
Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer
por: Ning-Yi Ma, et al.
Publicado: (2021)